José Luis
Fernández Sastre
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (1)
2008
-
A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia
International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149